Pulmonary Retransplantation: Predictors of Graft Function and Survival in 230 Patients
✍ Scribed by Richard J. Novick MD; Larry W. Stitt MSc; Khaled Al-Kattan MD; Walter Klepetko MD; Hans-Joachim Schäfers MD; Jean-Pierre Duchatelle MD; Asghar Khaghani MD; Robert L. Hardesty MD; G.Alexander Patterson MD; Magdi H. Yacoub MD
- Book ID
- 117038286
- Publisher
- Elsevier Science
- Year
- 1998
- Tongue
- English
- Weight
- 277 KB
- Volume
- 65
- Category
- Article
- ISSN
- 0003-4975
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Infection with hepatitis C virus (HCV) is the leading cause of liver transplantation (LT), while liver retransplantation (RT) for HCV is controversial as a result of concerns over poor outcomes. We sought to compare patient and graft survival after RT in patients with and without HCV. We performed a
End-stage liver disease secondary to hepatitis C virus (HCV) infection is the leading indication for liver transplantation in the United States. Recurrence of HCV infection is nearly universal. We studied the patients enrolled in the National Institute of Diabetes and Digestive and Kidney Diseases L